Guaifenesin; Pseudoephedrine Hydrochloride Patent Expiration
Guaifenesin; Pseudoephedrine Hydrochloride is Used for treating symptoms of respiratory congestion and congestion in the nasal passages. It was first introduced by Rb Health Us Llc
Guaifenesin; Pseudoephedrine Hydrochloride Patents
Given below is the list of patents protecting Guaifenesin; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex D | US6372252 | Guaifenesin sustained release formulation and tablets |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex D | US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex D | US7838032 | Sustained release of guaifenesin |
Apr 28, 2020
(Expired) | Rb Hlth |
Guaifenesin; Pseudoephedrine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List